Achievement of Clinical, Endoscopic, and Histological Outcomes in Patients with Ulcerative Colitis Treated with Etrasimod, and Association with Faecal Calprotectin and C-reactive Protein: Results From the Phase 2 OASIS Trial

By sjmartinez • June 4, 2024

Yarur AJ, Chiorean MV, Panés J, Jairath V, Zhang J, Rabbat CJ, Sandborn WJ, Vermeire S, Peyrin-Biroulet L. Achievement of Clinical, Endoscopic, and Histological Outcomes in Patients with Ulcerative Colitis Treated with Etrasimod, and Association with Faecal Calprotectin and C-reactive Protein: Results From the Phase 2 OASIS Trial. J Crohns Colitis. 2024 Jun 3;18(6):885-894. doi: 10.1093/ecco-jcc/jjae007. PMID: 38245818; PMCID: PMC11147797.

Tags: Cedars Sinai DoM, Digestive Diseases, endoscopic improvement–histologic remission, Etrasimod, mucosal healing, Publications, S1P receptor modulator, ulcerative colitis

Elevated ctDNA Tumor Fraction Is Associated with Improved Mutation Detection but Worse Overall Survival in Advanced Non-Small Cell Lung Cancer: a Lung-MAP Study

Mack PC, Redman MW, Tukachinsky H, Kozono DE, Minichiello K, Dragnev KH, Tolba KA, Neal JW, Madison RW, Waqar SN, Aggarwal C, Hirsch FR, Patel[...]

Topic Mapping to Inform Content to Discuss in Shared Decision-Making for Prostate Cancer

Friedrich NA, Kokorowski P, Luu M, Chaplin A, Polineni R, Shiang A, Shin D, Tan J, Freedland SJ, Spiegel B, Daskivich TJ. Topic Mapping to[...]

Long-Term Outcomes Following Catheter-Based Therapies in Older Adults With Acute Pulmonary Embolism

Watanabe A, Kuno T, Miyamoto Y, Ueyama HA, Gotanda H, Bangalore S, Tsugawa Y. Long-Term Outcomes Following Catheter-Based Therapies in Older Adults With Acute Pulmonary[...]